Why did BionTech update their agreement with Genentech on December 6, 2019?

They updated the contract to include terms regarding RNA manufacturing projects and sequencing.

What confidential RNA projects did they have in the pipeline in December 2019?

https://t.co/zihOtcilgo

Sidenote: a couple months before that, BionTech IPO'd.

Every $14 invested would have returned $389 at it's peak. A small return of 2,715%.

An investment into Moderna on the same date would've returned $418 at peak for every $14 invested — a 2,864% gain.

https://t.co/UsGA6bCAs3

BionTech's SEC filings admit that both the FDA and the European Union consider mRNA treatments as gene therapy. They also claim it's "high unlikely" these mRNA treatments will change your DNA.

Multiply "highly unlikely" by a couple billion people...

https://t.co/UGoobhzfeH

Moderna's SEC filings reflect the same language.

They note that they've made significant losses since inception. I wonder why? Why have they, who specialise in mRNA gene therapies, not had (and still don't have) a single FDA approved product? A mystery.

https://t.co/nMIO3APtgA

Dec 17th, 2019: European Investment Bank provides funding of €50 million to BioNTech as part of the Investment Plan for Europe

You could argue the EU now has a conflict of interest with pandemic response policies that could ultimately prop up BionTech.

https://t.co/PRKgYufQWv